Posts Tagged ‘Symtuza’
Counterfeit HIV drug underscores risks of a weaker drug supply chain, advocate warns.
ADAP Advocacy Association CEO Brandon M. Macsata wrote this editorial, which appeared on the AIDS Drug Assistance Program’s website on April 1, 2021.
The Association first warned constituents that counterfeit Symtuza had been distributed to three U.S. pharmacies in December 2020, when Janssen issued an alert.
[...]